plasma
-
Wnt/beta-catenin (other); MAPK (other); TGF-beta/SMAD (other); ceRNA regulation (other)
Microarray; RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
ROC analysis revealed hsa_circ_0001490 had an AUC of 0.792 (95% CI: 0.69-0.89; sensitivity: 93.5%; specificity: 67.4%) for predicting RHD.
hsa_circ_0001490 is up-regulated in RHD patient plasma and shows diagnostic value by ROC analysis. Bioinformatic ceRNA network prediction links it to multiple miRNAs and hub genes (e.g., MED17/CDK8), with enrichment in Wnt, MAPK and TGF-beta/SMAD-related terms, suggesting potential involvement in RHD pathogenesis.
0.5047
Expression profiles and bioinformatic analysis of circular RNA in rheumatic heart disease: potential hsa_circ_0001490 and hsa_circ_0001296 as a diagnostic biomarker.
combined biological and clinical study